Abstract:Currently available data describing the gene expression and regulation, secretion, distribution, and protein chemistry of osteopontin (OPN) all are consistent with the notions of this protein functioning as an inhibitor of mineralization and/or as a mediator of cell‐matrix and matrix‐matrix/mineral adhesion (cohesion) during the formation, turnover, and repair of normal and pathological mineralized tissues. The properties and overall integrity of mineralized tissues are in part dictated by the nature of their interfaces—sites where organic and inorganic components of the extracellular matrix interact to provide biomechanical strength, regulate mineral ion homeostasis, and influence cellular events involved in mineralized tissue modeling, remodeling, and repair. High‐resolution, colloidal‐gold immunocytochemistry has been used to characterize the proteinaceous composition of these interfaces and to establish that the phosphorylated sialoprotein, OPN, is a major component found at these sites where it accumulates as a dense, planar “coating” of organic material termed either a cement line or a lamina limitans. Structural/functional features of OPN predict an ability of this protein to regulate calcification in the matrix proper of mineralized tissues and to participate, more specifically, in cell‐matrix and matrix‐matrix/mineral adhesion in laminae limitantes and cement lines, respectively. From the ultrastructural immunocytochemical data presented herein for OPN illustrating the cellular expression and extracellular matrix distribution of this protein, it is demonstrated that the production of OPN is one of the earliest, and latest, secretory activities of the osteoblast lineage and that this activity manifests itself morphologically as a cement line or a lamina limitans, respectively, at bone matrix interfaces. In laminae limitantes at bone surfaces, OPN appears to be involved in osteoclast adhesion and possibly haptotaxis. An OPN‐containing cement line is also present at hard tissue interfaces in rat tooth, against osseointegrated titanium and hydroxyapatite implants and at the margins of surgically created bone defects—and there may influence biological adhesion in a manner similar to that proposed for normal bone. It is suggested, therefore, that in addition to its potential for influencing cell adhesion/dynamics in bones and teeth, OPN in cement lines may act as an interfacial adhesion promotor between apposing substrates, therein maintaining the overall integrity of bone during the bone remodeling sequence and “bonding” dissimilar tissues (or biocompatible materials) together in biological composites such as teeth and osseointegrated implants. © 1996 Wiley‐Liss, Inc.

Requirement of Calcium and Phosphate Ions in Expression of Sodium-Dependent Vitamin C Transporter 2 and Osteopontin in MC3T3-E1 Osteoblastic Cells.

Stimulation of Differentiation in Sodium-Dependent Vitamin C Transporter 2 Overexpressing MC3T3-E1 Osteoblasts

Zinc-induced Sodium-Dependent Vitamin C Transporter 2 Expression: Potent Roles in Osteoblast Differentiation

Activation of PKA and Phosphorylation of Sodium-Dependent Vitamin C Transporter 2 by Prostaglandin E2 Promote Osteoblast-Like Differentiation in MC3T3-E1 Cells.

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Osteopontin in Bone Metabolism and Bone Diseases

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss Via Suppressing Osteoclastogenesis in Mice

Change of osteopontin expression in the calcification of rat vascular smooth muscle cells induced by high phosphate and highcalcium media

NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling

Vitamin D Inhibition of TRPV5 Expression During Osteoclast Differentiation

[Nitric Oxide Regulates C-Fos Expression in Osteoblastic Cells Induced by Wall-Shear].

Phosphorylation of Osteopontin is Required for Inhibition of Calcium Oxalate Crystallization.

Regulation of Osteopontin Expression in a Rat Model of Urolithiasis

Roles of monocarboxylate transporter subtypes in promotion and suppression of osteoclast differentiation and survival on bone

Downregulation of the Ca2+-activated K+ channel KCa3.1 in mouse preosteoblast cells treated with vitamin D receptor agonist

Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair

Effects of vitamin D3 and vitamin K3 on the expression of osteopontin mRNA in rat kidney of stone model

Alterations of Ovariectomized Rat Bone and Impact of Non-Collagenous Proteins on Mineralization

Hormonally-Regulated Expression of Voltage-Operated Ca2+ Channels in Osteocytic (MLO-Y4) Cells

ClC-3 Chloride Channel Mediates the Role of Parathyroid Hormone [1-34] on Osteogenic Differentiation of Osteoblasts.

Regulatory actions of 3',5'-cyclic adenosine monophosphate on osteoclast function: possible roles of Epac-mediated signaling